Evaluation of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

Charfare H, Limongelli S, Purushotham AD, et al. Neoadjuvant chemotherapy in breast cancer. Br J Surg, 2005, 92: 14–23.

Wang XH, Geng DY, Gu YJ. The dynamic-contrast MRI manifestation of breast lesions. Radiol Pract (Chinese), 2005, 20: 662–666.

Yeh E, Slanetz P, Kopans DB, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR, 2005, 184: 868–877.

Junkermann H, Knopp MV, Schmid H, et al. Verlaufsbeobachtung des Mammakarzinoms unter praoperativer Chemotherapie mit Mammographie, Ultraschall und MR. In: Zentralblatt Radiologie. Berlin: Springer, 1994. 106.

Werner-Wasik M, Xiao Y, Pequignot E, et al. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study. Int J Radiat Oncol Biol Phys, 2001, 51: 56–61.

Shin KH, Moon SH, Suh JS, et al. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop 2000, 376: 200–208.

Pickles MD, Lowry M, Manton DJ, et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat, 2005, 91: 1–10.

Scott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat, 2005, 92:231–238.

Martincich L, Montemurro F, De Rosa G, et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrastenhanced magnetic resonance imaging. Breast Cancer Res Treat, 2004, 83: 67–76.

George ML, Dzik-Jurasz ASK, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg, 2001, 88: 1628–1636.

Balu-Maestro C, Chapellier C, Bleuse A, et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat, 2002, 72: 145–152.

Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer, 2002, 38: 2116–2127.

Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed, 2002, 15: 154–163.

Englmeier KH, Hellwig G, Griebel J, et al. Dynamic MR-mammography in virtual reality. Stud Health Technol Inform, 2003, 94: 72–78.

Knopp MV, Junkermann HJ, He B T, et al. MR-Mammographie zum Monitoring von neoadjuvanter Therapie beim Mammakarzinom. Radiologe, 1995, 35(Suppl 1): S81.

Chou CP, Wu MT, Chang HT, et al. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad Radiol, 2007, 14: 561–573.